Altimmune’s GLP-1 Drug Reduces Heavy Drinking in Alcohol Use Disorder TrialNews DeskJuly 28, 20260 GLP-1 drugs first made their mark in diabetes and obesity, but many research efforts are underway to bring such therapies…
GLP-1s Are Working — Now Medicine Needs to Measure What MattersNews DeskJuly 16, 20260 The GLP-1 era is here. The drugs are working. The pounds are coming off. But if we do not get…
Obesity Is Tied to Hundreds of Gene Variants — Why Are We Only Talking About Two?News DeskJuly 13, 20260 Glucagon-like peptide-1 (GLP-1) receptor agonist drugs are revolutionizing care for people with obesity, which affects more than 40% of U.S.…